SQZ Biotech Company
SQZ Biotech has sold its assets, including intellectual property and Cell Squeeze® technology, to STEMCELL Technologies Canada Acquisitions, Inc. The company has filed a Certificate of Dissolution with the Secretary of State of the State of Delaware. For inquiries about Cell Squeeze technology, contact STEMCELL at licensing@stemcell.com. For all other inquiries, contact Michael Jacoby at michael.jacoby@jsheld.com or contact@sqzbiotech.com. The company's contact information is PO Box 5515, Wayland, MA 01778.
Total Funding:
226415000
Employee Number:
101-250
Industry:
Gene therapy
Founded Date:
2013-01-01
Headquarters:
Watertown, Massachusetts, United States
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO